Urinary excretion of kallikrein is increased in patients with primary aldosteronism [59], in normal volunteers of patients with essential hypertension on a diet of low sodium or high potassium [51], after treatment with 9-fluorohydrocortisone [50], and in Bartter’s syndrome [60]. Here, KLK4 is linked to hypertensive disorder.